SciSparc Ltd. (NASDAQ:SPRC) Short Interest Update

SciSparc Ltd. (NASDAQ:SPRC) was the recipient of a large drop in short interest in February. As of February 15th, there was short interest totalling 65,200 shares, a drop of 66.9% from the January 31st total of 197,100 shares. Based on an average daily volume of 8,090,000 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.6% of the company’s stock are short sold.

SciSparc Price Performance

Shares of NASDAQ SPRC traded up $0.00 during mid-day trading on Friday, hitting $0.37. The stock had a trading volume of 114,765 shares, compared to its average volume of 6,471,790. The company has a 50 day moving average of $0.53 and a two-hundred day moving average of $0.36. SciSparc has a twelve month low of $0.20 and a twelve month high of $4.10.

SciSparc Company Profile

SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution.